Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.66M | -2.74M | -490.20K | -489.20K | -3.77M |
| Total Depreciation and Amortization | 66.00K | 67.90K | 67.50K | 67.40K | 69.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.16M | 3.25M | -1.17M | -1.17M | 1.58M |
| Change in Net Operating Assets | -- | -- | -1.85M | -1.85M | -- |
| Cash from Operations | 566.60K | 582.60K | -3.45M | -3.44M | -2.12M |
| Capital Expenditure | -800.00 | -800.00 | -2.20K | -2.20K | -500.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -800.00 | -800.00 | -2.20K | -2.20K | -500.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.70K | -14.70K | -24.70K | -24.70K | -21.20K |
| Issuance of Common Stock | 6.12M | 6.12M | 4.55M | 4.55M | 5.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -264.90K | -264.90K | -305.20K | -305.20K | -226.90K |
| Cash from Financing | 3.81M | 3.91M | 2.78M | 2.78M | 3.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.37M | 4.49M | -666.10K | -664.80K | 981.60K |